Bill
Bill > SF3063
MN SF3063
Reverse auction procurement requirement modification for SEGIP pharmacy benefit contracts
summary
Introduced
03/27/2025
03/27/2025
In Committee
03/27/2025
03/27/2025
Crossed Over
Passed
Dead
Introduced Session
94th Legislature 2025-2026
Bill Summary
A bill for an act relating to insurance; modifying the reverse auction procurement requirement for SEGIP pharmacy benefit contracts; prohibiting the use of spread pricing by pharmacy benefit managers; increasing pharmacy benefit manager license application fees; imposing fiduciary duties on pharmacy benefit managers; appropriating money; amending Minnesota Statutes 2024, sections 62W.02, by adding a subdivision; 62W.03, subdivisions 2, 3, 5; 62W.04; 62W.05, by adding a subdivision; 62W.06, subdivision 2; 62W.08; 62W.13; proposing coding for new law in Minnesota Statutes, chapter 62W.
AI Summary
This bill modifies regulations for pharmacy benefit managers (PBMs) in Minnesota, introducing several key provisions designed to increase transparency, fairness, and accountability in pharmaceutical pricing and services. The bill defines "spread pricing" as a pricing model where PBMs charge health plans a different price for prescription drugs than what they pay pharmacies, and explicitly prohibits this practice. It increases license application and renewal fees for PBMs from $8,500 to at least $15,000 and introduces more substantial penalties for violations. The bill establishes new fiduciary duties for PBMs, requiring them to act in good faith, discharge duties with care and professionalism, and not charge pharmacies fees for claim processing. It also mandates more transparent reporting requirements, including detailed annual transparency reports to the commissioner of commerce, and creates stricter rules around maximum allowable cost pricing, including a comprehensive appeals process for pharmacies. Additionally, the bill prohibits PBMs from reimbursing pharmacies less than they reimburse their own affiliates, ensures pharmacies are paid at least the national average drug acquisition cost, and prevents retroactive claim adjustments except under specific circumstances. The bill is accompanied by an appropriation to fund increased staff for investigating and enforcing these new PBM regulations.
Committee Categories
Business and Industry
Sponsors (1)
Last Action
Referred to Commerce and Consumer Protection (on 03/27/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Document Type | Source Location |
---|---|
State Bill Page | https://www.revisor.mn.gov/bills/bill.php?b=Senate&f=SF3063&ssn=0&y=2025 |
BillText | https://www.revisor.mn.gov/bills/text.php?number=SF3063&version=0&session=ls94&session_year=2025&session_number=0&format=pdf |
Loading...